Global Vaccines Market Growth 2025-2031

Publication ID:

LPI07255177

Publication Date:

July 4, 2025

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Vaccines market size is predicted to grow from US$ 51840 million in 2025 to US$ 72750 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
The 鈥淰accines Industry Forecast鈥� looks at past sales and reviews total world Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccines sales for 2025 through 2031. With Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segmentation by Application:
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vaccines market?
What factors are driving Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines market opportunities vary by end market size?
How does Vaccines break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines Sales by Type
2.3.1 Global Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccines Sale Price by Type (2020-2025)
2.4 Vaccines Segment by Application
2.4.1 Rabies vaccine
2.4.2 Influenza vaccine
2.4.3 HPV vaccine
2.4.4 Hepatitis B
2.4.5 Hepatitis A
2.4.6 Leprosy vaccine
2.4.7 Polio vaccine
2.4.8 JE vaccine
2.4.9 Others
2.5 Vaccines Sales by Application
2.5.1 Global Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccines Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Vaccines Breakdown Data by Company
3.1.1 Global Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccines Revenue by Company (2020-2025)
3.2.2 Global Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Vaccines Sale Price by Company
3.4 Key Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Product Location Distribution
3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Vaccines by Geographic Region
4.1 World Historic Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccines Sales Growth
4.4 APAC Vaccines Sales Growth
4.5 Europe Vaccines Sales Growth
4.6 Middle East & Africa Vaccines Sales Growth
5 Americas
5.1 Americas Vaccines Sales by Country
5.1.1 Americas Vaccines Sales by Country (2020-2025)
5.1.2 Americas Vaccines Revenue by Country (2020-2025)
5.2 Americas Vaccines Sales by Type (2020-2025)
5.3 Americas Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Sales by Region
6.1.1 APAC Vaccines Sales by Region (2020-2025)
6.1.2 APAC Vaccines Revenue by Region (2020-2025)
6.2 APAC Vaccines Sales by Type (2020-2025)
6.3 APAC Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vaccines by Country
7.1.1 Europe Vaccines Sales by Country (2020-2025)
7.1.2 Europe Vaccines Revenue by Country (2020-2025)
7.2 Europe Vaccines Sales by Type (2020-2025)
7.3 Europe Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccines by Country
8.1.1 Middle East & Africa Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines
10.3 Manufacturing Process Analysis of Vaccines
10.4 Industry Chain Structure of Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Distributors
11.3 Vaccines Customer
12 World Forecast Review for Vaccines by Geographic Region
12.1 Global Vaccines Market Size Forecast by Region
12.1.1 Global Vaccines Forecast by Region (2026-2031)
12.1.2 Global Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccines Forecast by Type (2026-2031)
12.7 Global Vaccines Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines Product Portfolios and Specifications
13.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines Product Portfolios and Specifications
13.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novartis(GSK)
13.5.1 Novartis(GSK) Company Information
13.5.2 Novartis(GSK) Vaccines Product Portfolios and Specifications
13.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Novartis(GSK) Main Business Overview
13.5.5 Novartis(GSK) Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines Product Portfolios and Specifications
13.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines Product Portfolios and Specifications
13.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines Product Portfolios and Specifications
13.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines Product Portfolios and Specifications
13.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines Product Portfolios and Specifications
13.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines Product Portfolios and Specifications
13.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines Product Portfolios and Specifications
13.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines Product Portfolios and Specifications
13.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 Jintan
13.14.1 Jintan Company Information
13.14.2 Jintan Vaccines Product Portfolios and Specifications
13.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Jintan Main Business Overview
13.14.5 Jintan Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂